Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.
Main Authors: | Mehta, Z, Manley, S, Zimmett, P, Bottazzo, G, Cull, C, Holman, R, Turner, R, Grp, U |
---|---|
格式: | Journal article |
出版: |
1999
|
相似书籍
-
UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
由: Turner, R, et al.
出版: (1997) -
UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
由: Turner, R, et al.
出版: (1997) -
Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
由: Davis, T, et al.
出版: (2005) -
Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
由: Clark, A, et al.
出版: (2005) -
Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS
由: Cull, C, et al.
出版: (1999)